Vaishali Pharma Limited (NSE:VAISHALI)
12.05
-0.12 (-0.99%)
Sep 10, 2025, 3:30 PM IST
Vaishali Pharma Revenue
Vaishali Pharma had revenue of 237.47M INR in the quarter ending June 30, 2025, with 31.35% growth. This brings the company's revenue in the last twelve months to 1.05B, up 15.13% year-over-year. In the fiscal year ending March 31, 2025, Vaishali Pharma had annual revenue of 990.26M with 14.77% growth.
Revenue (ttm)
1.05B
Revenue Growth
+15.13%
P/S Ratio
1.50
Revenue / Employee
38.78M
Employees
27
Market Cap
1.57B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 990.26M | 127.46M | 14.77% |
Mar 31, 2024 | 862.80M | 166.17M | 23.85% |
Mar 31, 2023 | 696.63M | -61.58M | -8.12% |
Mar 31, 2022 | 758.21M | 220.47M | 41.00% |
Mar 31, 2021 | 537.74M | -63.12M | -10.50% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.04B |
Vaishali Pharma News
- 1 year ago - Vaishali Pharma shares surge 3% after company plans on ambitious growth strategy - Business Upturn
- 1 year ago - Vaishali Pharma to explore merger and acquisition strategy in upcoming board meeting on October 3 - Business Upturn
- 1 year ago - Vaishali Pharma Ltd (NSE:VAISHALI) Q3 2024 Earnings Call Transcript Highlights: Strong ... - GuruFocus